Panels Take First Cuts at 1989 Budget

WASHINGTON--The $3.3 billion increase in spending for science and space programs proposed by the administration for 1989 is shrinking rapidly as it begins to make its way through Congress. On March 17 the House Budget Committee sliced the request in half. But the panel’s non-binding reductions in spending authority varied greatly by agency. The National Science Foundation, for example, received $300 million of its $330 million increase, while the $400 million increase for general scienc

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

On March 17 the House Budget Committee sliced the request in half. But the panel’s non-binding reductions in spending authority varied greatly by agency. The National Science Foundation, for example, received $300 million of its $330 million increase, while the $400 million increase for general sciences within the Department of Energy, which contains a $363 million request for the Superconducting Supercoilider, was whittled down to just $100 million. The $2.55 billion increase sought by NASA, including funds for the space station, was shrunk to $1.25 billion more.

The budget committee’s recommendation was adopted March 23 by the full House and then quickly forwarded to the Senate. Although its figures offer an indication of congressional sentiment, the real spending levels are set by the appropriations committees in each house.

That process also began last month with subcommittee hearings at which science administrators tried to defend their requests. That discussion, although cordial, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies